Accenture Makes Strategic Investment in ixlayer to Expand Access to Virtual Diagnostic Health Testing

NEW YORK; Aug. 24, 2021 – Accenture (NYSE: ACN) has made a strategic investment, through Accenture Ventures, in ixlayer, a provider of technology-based solutions for diagnostic testing. The company’s telehealth platform allows players across the healthcare ecosystem to offer convenient and scalable health testing in a virtual environment. 

Comments

Popular posts from this blog

Add Custom Field in Output of Standard Report of ME2N

UK to Receive Egyptian LNG Cargo

HANA Housekeeping using HANACleaner